Inventor · disambiguated record
Kazunori Hirayama
Also filed as: HIRAYAMA KAZUNORI
8 granted patents·5 pending applications·12 citations·filing 2017–2025
80Inventor score
Top patents by PatentIndex Score
13 records- 0191US10517966B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2017·Granted Dec 31, 2019·5 cites·32 claims
- 0289US10507251B2Anti-human MUC1 antibody fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Dec 17, 2019·3 cites·17 claims
- 0387US11679166B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Jun 20, 2023·2 cites·21 claims
- 0485US11521685B2Semiconductor storage deviceKIOXIA CORP·Filed 2021·Granted Dec 6, 2022·2 cites·19 claims
- 0567US11915765B2Semiconductor storage deviceKIOXIA CORP·Filed 2022·Granted Feb 27, 2024·0 cites·18 claims
- 0667US2020171174A1Novel anti-human muc1 antibody fab fragmentASTELLAS PHARMA INC·Filed 2019·Application pending·0 cites
- 0766US12227586B2Anti-CLDN4/anti-CD137 bispecific antibodyASTELLAS PHARMA INC·Filed 2022·Granted Feb 18, 2025·0 cites·25 claims
- 0864US2024404622A1Method for preparing prefilled syringe formulationCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0959US2022096653A1Conjugate comprising ligand and ceacam5 antibody fab fragmentASTELLAS PHARMA INC·Filed 2020·Application pending·0 cites
- 1059US2024400693A1Drug formulation of anti-hla-dq2.5 antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1156US2025154272A1Anti-cldn4/anti-cd137 bispecific antibodyASTELLAS PHARMA INC·Filed 2025·Application pending·0 cites
- 1252US11667724B2Anti-human CEACAM5 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2018·Granted Jun 6, 2023·0 cites·35 claims
- 1346US12202908B2Complex having anti-human MUC1 antibody Fab fragment, peptide linker and/or ligandASTELLAS PHARMA INC·Filed 2019·Granted Jan 21, 2025·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Kazunori Hirayama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →